Company
United StatesPublic company, NYSE: HAEHaemonetics Corporation (NYSE: HAE), Boston, MA – FDA Inspections
Inspection records and compliance data for Haemonetics Corporation in Boston, Massachusetts. 4 FDA inspections on record, 1 Form 483, last inspected December 20, 2018. Publicly traded as NYSE: HAE.
Company Profile
This profile covers Haemonetics Corporation based in Boston, Massachusetts, United States.
FDA Inspection History
- FDA inspections
- 4
- OAI
- 0
- VAI
- 1
- NAI
- 2
- Unclassified
- 1
- Form 483s
- 1
- Warning letters
- 0
First inspected September 19, 2011. Last inspected December 20, 2018.
FDA inspections (4)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| December 20, 2018 | NAI | Medical Devices & Rad Health · Bioresearch Monitoring | 1078708 |
| August 31, 2017 | Not classified | Medical Devices & Rad Health | 1045923 |
| February 7, 2014 | NAI | Medical Devices & Rad Health · Compliance: Devices | 866083 |
| September 19, 2011 | VAI | Medical Devices & Rad Health · Compliance: Devices | 745197 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Haemonetics Corporation
Stock ticker
HAE
Exchange
NYSE
Share price
$123.26
Market cap
$5.6B
Price as of
November 6, 2026
FEI Number
1219343
Address
125 Summer St, Boston, Massachusetts 02110, United States
Country
United States
ID: 26e3fc8a-a55d-40bf-a349-4a49e7f5f57f